These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Combination of a two-step fluorescence assay and a two-step anti-Factor Xa assay for detection of heparin falsifications and protein in heparins. Alban S; Lühn S; Schiemann S Anal Bioanal Chem; 2011 Jan; 399(2):681-90. PubMed ID: 20953779 [TBL] [Abstract][Full Text] [Related]
28. Contaminated heparin associated with adverse clinical events and activation of the contact system. Kishimoto TK; Viswanathan K; Ganguly T; Elankumaran S; Smith S; Pelzer K; Lansing JC; Sriranganathan N; Zhao G; Galcheva-Gargova Z; Al-Hakim A; Bailey GS; Fraser B; Roy S; Rogers-Cotrone T; Buhse L; Whary M; Fox J; Nasr M; Dal Pan GJ; Shriver Z; Langer RS; Venkataraman G; Austen KF; Woodcock J; Sasisekharan R N Engl J Med; 2008 Jun; 358(23):2457-67. PubMed ID: 18434646 [TBL] [Abstract][Full Text] [Related]
29. Determination of Oversulphated Chondroitin Sulphate and Dermatan Sulphate in unfractionated heparin by (1)H-NMR - Collaborative study for quantification and analytical determination of LoD. McEwen I; Mulloy B; Hellwig E; Kozerski L; Beyer T; Holzgrabe U; Wanko R; Spieser JM; Rodomonte A Pharmeuropa Bio; 2008 Dec; 2008(1):31-9. PubMed ID: 19220979 [TBL] [Abstract][Full Text] [Related]
30. [Antiocoagulant activity of chondroitin sulfate A, B and C.--co-operative action with heparin cofactor (author's transl)]. Shiba T; Takeuchi S; Awazu S; Igarashi M; Asada T Nihon Ketsueki Gakkai Zasshi; 1978 Jun; 41(3):560-3. PubMed ID: 696196 [No Abstract] [Full Text] [Related]
31. Composition of OSCS-contaminated heparin occurring in 2008 in batches on the German market. Beyer T; Matz M; Brinz D; Rädler O; Wolf B; Norwig J; Baumann K; Alban S; Holzgrabe U Eur J Pharm Sci; 2010 Jul; 40(4):297-304. PubMed ID: 20399266 [TBL] [Abstract][Full Text] [Related]
32. Lessons learned from the contamination of heparin. Liu H; Zhang Z; Linhardt RJ Nat Prod Rep; 2009 Mar; 26(3):313-21. PubMed ID: 19240943 [TBL] [Abstract][Full Text] [Related]
33. New developments in quantitative polymerase chain reaction applied to control the quality of heparins. Auguste C; Dereux S; Martinez C; Anger P Anal Bioanal Chem; 2011 Jan; 399(2):747-55. PubMed ID: 20931175 [TBL] [Abstract][Full Text] [Related]
34. (1)H NMR signal at 2.10 ppm in the spectrum of KMnO(4)-bleached heparin sodium: identification of the chemical origin using an NMR-only approach. Kellenbach E; Sanders K; Michiels PJ; Girard FC Anal Bioanal Chem; 2011 Jan; 399(2):621-8. PubMed ID: 21069304 [TBL] [Abstract][Full Text] [Related]